Clorox Company (CLX)

In the past six months, Clorox stock faced headwinds, including a 52-week low in June 2025. The fiscal third-quarter earnings report in May 2025 revealed a miss on both revenue and EPS, with organic sales declining by 2% year-over-year. Clorox trimmed its annual sales forecast due to weak consumer demand and an ongoing ERP system transition, which is expected to cause sales volatility. Despite these challenges, Clorox has raised dividends for 48 consecutive years.

Demand for Clorox's products has been impacted by macroeconomic uncertainties, leading to changes in shopping behaviors and temporary category slowdowns. While specific seasonal patterns are not explicitly detailed, the company noted limited seasonal demand growth in the third quarter of fiscal year 2025. As a consumer staples company, its products generally experience more stable demand compared to discretionary goods.

The Clorox Co. is a multinational manufacturer and marketer of consumer and professional products in the consumer staples sector. Its portfolio includes brands across health and wellness, household, and lifestyle segments, such as Clorox, Glad, Kingsford, and Burt's Bees.

The Clorox Company has a significant global presence, with products sold in over 100 countries. It has manufacturing facilities, R&D centers, sales offices, and distribution networks across North America, South America, Europe, Asia-Pacific, and the Middle East. The company manages all foreign operations from its international division headquarters in Miami.

Clorox's brand reputation has been influenced by operational challenges, particularly the lingering effects of a cyberattack in August 2023. The company has been in "prove-it mode" as investors assess its recovery from these disruptions. Despite these setbacks, Clorox has focused on brand building through advertising investments and has maintained overall market shares, while also unveiling new product innovations.

Institutional investors hold a significant portion of Clorox stock, with 78.53% owned by hedge funds and other institutional investors. Vanguard Group Inc. increased its stake by 0.4% in the first quarter of 2025. Corporate insiders own 0.63% of the stock.